Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis?

A. Bush

Source: Breathe 2008; 4: 365

Journal Issue: June

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bush. Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis?. Breathe 2008; 4: 365

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Libor Fila - 25.06.2008 21:34
Sorry, there is page 364

You must Login to comment this presentation.

Related content which might interest you:

Cystic fibrosis lung disease: from molecular defect to abnormal mucocilliary clearance Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics Year: 2007
Cystic fibrosis and bone disease: are we missing a genetic link? Source: Eur Respir J 2005; 25: 9-11 Year: 2005
Elucidating progression of early cystic fibrosis lung disease Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017 Year: 2017
How much genotype influences cystic fibrosis associated liver disease? Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006
New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006
The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018 Year: 2019
Cystic fibrosis related pulmonary disease: more structure than function? Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005
Peptide transport mechanisms in cystic fibrosis and normal human lung Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001
A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011
Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014
A model for active and healthy ageing with a rare genetic disease: cystic fibrosis Source: Eur Respir J 2016; 47: 714-719 Year: 2016
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Longitudinal changes in lung function and the association with pulmonary structure and infection in infants with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010
Comparison of progression in lung structure and lung function in children and adolescents with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006
Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014
The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013
Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020